Deng; Zhengwu J.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Deng; Zhengwu J..The latest application filed is for "low molecular weight cationic lipids for oligonucleotide delivery".
- Deng; Zhengwu J. - Eagleville PA
- Deng, Zhengwu J. - Norristown PA
| Patent | Date |
|---|---|
| Low molecular weight cationic lipids for oligonucleotide delivery Grant 9,725,720 - Bawiec, III , et al. August 8, 2 | 2017-08-08 |
| Low Molecular Weight Cationic Lipids For Oligonucleotide Delivery App 20170015998 - BAWIEC, III; John A. ; et al. | 2017-01-19 |
| Low molecular weight cationic lipids for oligonucleotide delivery Grant 9,458,087 - Bawiec, III , et al. October 4, 2 | 2016-10-04 |
| P2X3 receptor antagonists for treatment of pain Grant 9,238,647 - Burgey , et al. January 19, 2 | 2016-01-19 |
| Low Molecular Weight Cationic Lipids For Oligonucleotide Delivery App 20150284316 - BAWIEC, III; John A. ; et al. | 2015-10-08 |
| Low molecular weight cationic lipids for oligonucleotide delivery Grant 9,029,604 - Bawiec, III , et al. May 12, 2 | 2015-05-12 |
| P2X3, receptor antagonists for treatment of pain Grant 8,598,209 - Burgey , et al. December 3, 2 | 2013-12-03 |
| P2X.sub.3 receptor antagonists for treatment of pain Grant 8,569,512 - Burgey , et al. October 29, 2 | 2013-10-29 |
| Low Molecular Weight Cationic Lipids For Oligonucleotide Delivery App 20130274523 - Bawiec, III; John A. ; et al. | 2013-10-17 |
| P2X3 Receptor Antagonists for Treatment of Pain App 20120064181 - Burgey; Christopher S. ; et al. | 2012-03-15 |
| P2x3 Receptor Antagonists For Treatment Of Pain App 20120015052 - Burgey; Christopher S. ; et al. | 2012-01-19 |
| CGRP receptor antagonists Grant 8,039,460 - Burgey , et al. October 18, 2 | 2011-10-18 |
| P2x3, Receptor Antagonists For Treatment Of Pain App 20110206783 - Burgey; Christopher S. ; et al. | 2011-08-25 |
| CGRP receptor antagonists Grant 7,632,832 - Burgey , et al. December 15, 2 | 2009-12-15 |
| CGRP receptor antagonists Grant 7,534,784 - Burgey , et al. May 19, 2 | 2009-05-19 |
| CGRP receptor antagonists App 20080280857 - Burgey; Christopher S. ; et al. | 2008-11-13 |
| Cgrp Receptor Antagonists App 20080125413 - Burgey; Christopher S. ; et al. | 2008-05-29 |
| Cgrp Receptor Antagonists App 20080113966 - Burgey; Christopher S. ; et al. | 2008-05-15 |
| CGRP receptor antagonists App 20070225272 - Burgey; Christopher S. ; et al. | 2007-09-27 |
| CGRP receptor antagonists Grant 7,235,545 - Burgey , et al. June 26, 2 | 2007-06-26 |
| CGRP receptor antagonists App 20050256098 - Burgey, Christopher S. ; et al. | 2005-11-17 |
| CGRP receptor antagonists Grant 6,953,790 - Burgey , et al. October 11, 2 | 2005-10-11 |
| CGRP receptor antagonists App 20040229861 - Burgey, Christopher S. ; et al. | 2004-11-18 |
| Thrombin inhibitors App 20030225131 - Burgey, Christopher S. ; et al. | 2003-12-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 